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Assessment and Management of Cauda Equina Syndrome 
Abstract 
Introduction 
Cauda equina syndrome (CES) is a rare condition that affects the nerves in the spine supplying the 
bladder, bowel and sexual function.  Identification and subsequent urgent action is required to  
avoid permanent damage to these essential organs. Delays in diagnosis can have devastating and life 
changing consequences for patients and result in high cost negligence claims. 
Purpose 
The purpose of this paper is to examine the current evidence and provide a consistent approach in 
the safe management of patients presenting with CES. It will include a focus on the importance of 
communication, documentation and a practical approach to safety netting those at risk.   
Implications for practice  
CES has significant implications for patients and clinicians alike.  Timely, effective diagnosis and 
management of patients with CES results in a better outcome. 
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Introduction 
Cauda Equina Syndrome (CES) is a challenging condition to diagnose and manage. It may present at 
any time or in any setting and it is imperative that clinicians are able to quickly reason through their 
findings to manage the patient effectively. The purpose of this paper is to highlight the many 
challenges faced by clinicians in recognising and managing the condition and will offer guidance on 
the evidence based management of these patients.   
There are many causes of CES, but the most common cause is that of a lumbar spine disc herniation 
and occurs most frequently between the ages of 31-50 (Fuso et al, 2013). Cauda equina compression 
usually occurs as a result of a disc prolapse, often at the L4/5 level (Fraser et al, 2009). However, any 
space-occupying lesion, such as spinal stenosis, tumour, cysts, infection or bony ingress can narrow 
the spinal canal and cause compression of the cauda equina.  So what is the scale of the problem?  
Most literature agrees that within the total back pain population CES is a rare condition.  In 1994, 
The Clinical Standards Advisory Group suggested that serious pathology comprised just 1% of all 
back pain, with CES being just one of the many serious conditions that can lead to back pain (CSAG 
1994, Verhagen et al, 2016).  Despite CES being estimated to have a very low prevalence of just 0.04 
(Jarvik, 2002), it is considered to be a major problem internationally and multiple National 
Guidelines for the management of low back pain refer to the importance of screening for CES 
(Verhagen et al 2016).  It is important to note that whilst the published evidence is that in the 
general population CES is rare, in an eighteen-month period in a Primary Care Interface service in the 
UK, 28 positive CES patients were managed as emergency cases and referred to a specialist spinal 
service, representing 3.5% of the service’s patient population. In 1995 the Office of National 
Statistics estimated that in the UK one CES patient will present annually for every 50,000 patients 
seen in primary care, the equivalent of 0.002%. These varying statistics appear to be contradictory, 
however, they can be explained by understanding the clinical context in which these patients were 
seen. Underwood (2009) states that a GP will see one CES patient in their entire career yet Fairbank 
(2014) identifies that 1000 operations are carried out per year in the UK for CES. The incidence of 
CES patients attending a particular medical setting depends on the type of the medical service 
provided.  Spinal surgeons will always see more CES patients than a GP, and physiotherapists will 
probably see a number in between depending where on the patient pathway they sit.  
Physiotherapists working at an advanced practice level are likely to see more patients with CES as 
their patient population is likely to be more complex.  Patients seeing advanced practitioners will 
often have previously failed conservative intervention or may have more serious health problems. 
Regardless of the healthcare setting or clinician, it is still important to have a framework, which 
supports the early identification and management of patients with suspected CES. Timely diagnosis 
is essential to avoid life-changing outcomes for patients; it is estimated that one fifth of patients will 
have a poor outcome, with on-going treatment for bladder, bowel and sexual dysfunction, along 
with significant psychosocial consequences (Gardner et al, 2011). 
The best and most widely used model that currently exists to aid in the identification of CES is the 
system of Red Flags, although these previously considered cornerstones of safe practice have been 
called into question. Underwood and Buchbinder (2013) suggest that screening for red flags in 
general is “a popular idea that didn’t work and should be removed from guidelines”.  A number of 
authors including Henschke & Maher (2006), Downie et al (2013) and Verhagen et al (2016) have 
published high quality review papers demonstrating that Red Flags have a weak evidence base.  
These systematic reviews have focused on the diagnostic accuracy of specific Red Flags. Due to the 
combined challenges of the relatively rare prevalence of serious pathology in the total back pain 
population, and the significant difficulty in designing high quality studies in this area, the findings 
that most Red Flags are not good predictors of serious pathology, is unsurprising.  Most recently 
Cook et al (2017) called for a paradigm shift away from Red Flags stating “…red flag screening is not 
consistent with best practice in LBP management”. 
In light of this, it would be fair to question the utility of current red flags for CES and to ask what can 
we do as treating physiotherapists to manage these patients.  To answer this question, it is useful to 
go back to basics and consider the clinical interaction between a physiotherapist and a patient 
arriving for their first appointment with a complaint of low back pain, whether it is 4pm on a Friday 
or first thing Monday morning. The physiotherapist needs to decide in a limited timeframe whether 
the patient’s problem is suitable for physiotherapy management (keep), or whether the patient 
needs to be referred to other medical personnel or sent for further investigation (refer) and if so, in 
what time frame (emergency/soon/routine). 
These are vital decisions to make, as CES can have permanent life changing consequences if not 
acted upon in a timely manner; in the UK the current guidance is that patients should be sent for an 
emergency MRI and surgical opinion on the same day (Germon et al, 2015).  The physiotherapist has 
a professional duty of care and a legal responsibility to provide appropriate and timely care. In cases 
of suspected CES this duty is clearly to refer rather than to keep. 
Current World Confederation for Physical Therapy (WCPT) guidelines describe the keep/refer 
decision making as a core element of physiotherapy practice around the management of patients 
with potentially serious medical pathology (WCPT, 2011), and this is clearly the case with CES. So, if 
the current Red Flags do not withstand scrutiny, what should we use to inform our keep/refer 
decision with a patient in front of us who may have CES? Clinicians must be able to identify true CES 
from the many conditions that can masquerade as CES, using sensitive and thorough questioning 
and examination.  
Definition of CES 
In the past there has been little consensus in the literature as to how CES is defined. For example 
Fraser et al, (2009) reported that were 17 different definitions of CES. However, this is improving and 
5 characteristic features of CES are now becoming consistently recognised (Todd and Dickson, 2016) 
1. Bilateral neurogenic sciatica - Pain associated with the back and/or unilateral/bilateral leg 
symptoms may be present. 
2. Reduced perineal sensation - Sensation loss in the perineum and saddle region is one of the 
most commonly reported symptoms. 
3. Altered bladder function leading to painless urinary retention - Bladder dysfunction is the 
other most commonly reported symptom and can range from increased urinary frequency, 
difficulty in micturition, change in urine stream, urinary incontinence and urinary retention. 
4. Loss of anal tone - loss or reduced anal tone may be evident if a patient reports bowel 
dysfunction. Bowel dysfunction may include faecal incontinence, inability to control bowel 
motions, inability to feel when the bowel is full with consequent overflow. 
5. Loss of sexual function - Sexual dysfunction is not widely mentioned in the literature but is 
an important aspect of health and wellbeing that needs discussion with patients, despite the 
potential embarrassment for both patient and therapist. 
These features are key in helping to standardise the assessment of these patients and should form 
the basis of the subjective and physical examination of any patient suspected of having CES.  
The British Association of Spinal Surgeons (BASS) has produced a statement which is clinically useful 
and reflects the above 5 features, stating that  “a patient presenting with acute low back pain with a 
suggestion of a disturbance of their bladder or bowel function and/or saddle sensory disturbance 
should be suspected of having CES”( Germon et al, 2015). 
One of the key issues which has important ramifications for physiotherapy practice, (in particular the 
initial keep/refer decision), is that early symptoms of CES are often subtle and vague (Bin et al, 2009, 
Sun et al, 2014). This is compounded by the fact that as the condition progresses, the signs and 
symptoms do not develop in a recognised pattern (Bin et al,2009).  Sun et al (2014) confirm that 
there is no set chronology of presenting symptoms, creating uncertainty and difficulty with early 
diagnosis. This is particularly challenging for physiotherapists who often rely on pattern recognition 
to inform clinical decision making, however knowing that that there is no pattern to look for is 
paradoxically actually quite useful (Greenhalgh et al, 2015).   Todd and Dickson (2016) describe four 
separate stages of CES (Table 1), which are characterised by progressive sensory and motor deficits 
in lower extremities.  
 
 
Table 1.  Four stages of CES (Todd and Dickson 2016) 
CESS 
Suspected 
 Bilateral radicular pain  
 
CESI 
Incomplete 
Urinary difficulties of neurogenic origin 
 Altered urinary sensation 
 Loss of desire to void 
 Poor urinary stream 
 Need to strain to micturate 
CESR 
Retention 
Neurogenic retention of urine 
 Painless urinary retention and overflow 
incontinence where the bladder is no longer 
under executive control  
CESC 
Complete 
 Objective loss of CE function 
 Absent perineal sensation 
 Patulous anus (spread open) 
  Paralysed insensate bladder and bowel 
 
The boundary between these stages is blurred rather than discrete and the probability of a CES 
patient progressing through the stages e.g. from CESS through to CESR and how quickly this may 
occur cannot be predicted. 
In light of the above definition and guidance, what should we be doing to help us make a clinical 
decision about whether to keep or refer the patient? 
 
Subjective Examination 
The subjective history is the most important aspect of the examination, particularly early in the 
presentation of a patient with CES, as the subtle and vague symptoms related to early CES need to 
be identified using clear and unambiguous methods of communication (Bin et al, 2009, Sun, 2014). 
However, in the context of severe pain, patients with CES have expressed their difficulty in 
concentrating on clinical questions, especially when they appear to have no relevance to the pain 
they are suffering e.g. ‘what has bladder function got to do with my severe back pain?’ (Greenhalgh 
et al, 2015). Patients with severe pain that is all-encompassing may also struggle to identify early 
subtle changes in bladder and bowel function and in saddle sensation (Whitaker at al, 2015). 
It goes without saying that good communication is a core requisite skill in physiotherapy practice 
and in the clinical context these skills are honed over time, with the experience of many hours of 
patient contact (patient ‘mileage’).  However, what is occasionally overlooked is the patient’s need 
to understand the relevance of the questions they are being asked, and their need to fully 
appreciate the importance of the questions or of the consequences of the answers given, especially 
in the presence of severe pain. 
Greenhalgh et al (2015) found that one of the key problems in communication was the technical/ 
medical language used by clinicians. The patient participants in the study emphasised the need for 
clinicians to use clear and some would say explicit language that could be readily understood during 
a consultation. For example, male patients understood clearly ‘Do you have a change in ability to get 
an erection or ejaculate?’  However, when questioned about ‘problems with sexual function’ patients 
all thought that the question related to being sexually active.  
The patients went on to suggest that a CES cue card may be helpful for clinicians to use during the 
subjective examination, firstly to help frame, and then focus attention during this part of the 
assessment on the important and sensitive CES questions (Figure 1). It could also help clinicians 
avoid some of the embarrassment associated with asking some of the more sensitive questions. The 
patients also suggested that the CES cue card should map against a patient credit card (Figure 2), 
using the same questions that the patient could keep for future reference. The patient credit card 
contains additional information including timely action to take should symptoms develop. The credit 
card can also be used by patients to facilitate future clinical communication, particularly in 
emergency settings, to help express embarrassing yet clinically important symptoms. (This card is 
available in 30 different languages). A patient in the study reflected, 
“If I had gone to the GP and he had given me a card with CES [on]…I could have been probably in A&E 
at the weekend rather than wait until Wednesday…so it would have been 2 or 3 days prior that I 
could have been in” (Gareth) 
 Figure 1 CES  Clinical Cue Card reproduced with permission from Sue Greenhalgh and James Selfe 
 
 
Figure 2 CES Patient Credit Card reproduced with permission from Sue Greenhalgh and James Selfe 
During the subjective examination establishing the chronology of the history of the present 
condition in detail is key as timing is of paramount importance in the successful management of 
CES.  The onset of back and or leg pain is significant but precisely when symptoms relating to the 
parasympathetic nerve supply began is critical. As stated earlier there is no way of predicting who 
will progress from Cauda Equina Suspected (CESS) to Cauda Equina in Retention (CESR), or how 
quickly this may happen (Table 1), so the importance of precise recording of the timing of 
chronology cannot be overestimated.   Clinicians need to clearly establish if symptoms are better, 
worse or the same. Improving pain does not necessarily mean the condition is improving. Improved 
neurological status must be confirmed before this can be assumed.  Establishing the pattern of pain 
through 24 hours and recording the precise area of pain, pins and needles and numbness is 
essential. Establish if these symptoms have been experienced before or if they are new or different 
in some way?  Further questioning should include the following; 
• What treatments have been tried (including medication), is helpful on a number of levels.  
Many medications cause symptoms that masquerade as CES (Woods e al, 2015). This does not mean 
that symptoms can be ignored and attributed to drugs; however, medication could be contributing 
to the bladder, bowel and sexual dysfunction (Table 2). Similarly, pain can cause bladder retention.   
• What is the past medical history status? Previous diagnosis of disc pathology or spinal 
stenosis may be significant.  Previous history of serious conditions such as cancer must be noted and 
may be important. Similarly many co-morbidities could masquerade as CES e.g. Diabetes, Multiple 
Sclerosis, Benign prostatic hyperplasia, (Woods et al, 2015).  
• Has there been any recent or past spinal surgery and/or any history of osteoporosis?  Cauda 
Equina Compression is not solely caused by discal compression but could be from a mass caused by 
infection or haematoma.  Similarly, a fragment of bone from a retro-pulsed vertebral insufficiency 
fracture could cause CES. Medication comorbidities are discussed later.   
Once the subjective history gives a suggestion of CES a full physical examination should be 
undertaken. 
Physical Examination 
 A full neurological assessment should be performed to establish if any dermatomal sensory loss, 
myotomal weakness or reflex change is present. If there are any suspicions of a higher lesion or 
central nervous system lesion causing symptoms, then upper motor neurone tests such as the 
plantar (Babinski) response, clonus testing, muscle tone testing, joint position sense and gait should 
also be included in the examination.  
A digital rectal examination (DRE) is currently considered in UK guidelines as essential to evaluate 
loss of anal sphincter tone (Todd & Dickson, 2016). Whilst this is an established test for patients with 
suspected CES, the evidence for its use is weak, and there is now some debate as to whether it 
should be included in the examination at all. The evidence suggests that there is no direct 
correlation between a finding of decreased anal tone and the presence of cauda equina compression 
on MRI scan (Gooding et al 2012) and that the physical tests have low sensitivity and specificity 
(Balasubramanian et al 2010: Bell et al 2007).  The reliability of the test has also been shown to be 
variable, as has the written documentation of findings of the examination (Tudose et al 2017). Any 
clinician opting to carry out a DRE must be appropriately trained and competent in the procedure; it 
is also mandatory that a chaperone is offered to the patient during this sensitive examination.  
Current evidence suggests that the presence of sensory disturbance in the saddle region is a more 
valid and reliable indicator of CES (Gitelman et al 2017;). Sensation to light touch and pin prick 
throughout the saddle region including buttocks, inner thighs and perianal region must also be 
tested (Todd and Dickson, 2016). Like DRE testing, these ‘intimate’ tests must only be performed by 
an appropriately trained clinician with a chaperone for the benefit of both the patient and the 
clinician. 
The ultrasound assessment of residual bladder volume post voiding is commonly used in the 
emergency department to help test for CES. Again, whilst this is widely used, the evidence to 
support its validity in assessment for CES is not well established, as authors have suggested a variety 
of residual volumes (100/200/500ml) may be important (Domen et al 2009; Angus et al 2015; 
Venkatesan et al 2015).  
We recognise that there is ongoing discussion and a current lack of consensus about which specific 
physical tests should be used to help with the diagnosis of CES, especially DRE.  However, guidelines 
recommend that a full neurological examination including saddle sensory testing for light touch and 
pin-prick, and anal tone testing is undertaken in the presence of a chaperone by clinicians who are 
trained and competent to do so. Failure to undertake this battery of tests and gain as complete a 
clinical picture as possible may leave the clinician open to challenge and potential litigation. 
CES Masqueraders 
As Germon et al (2015) point out, in the population of patients investigated with MRI to confirm or 
negate CES a significant number will not have CES. There are many causes for symptoms that 
masquerade as CES adding to the challenge of accurate and timely diagnosis, this includes co-
morbidities and perhaps less well known the effects and side effects of some prescription 
medication, which may be responsible for masquerading symptoms. This includes a number of drugs 
not prescribed for pain relief. Cholinergic and Anticholinergic drugs influence the parasympathetic 
nervous system with cholinergic drugs mirroring parasympathetic nervous activity, anticholinergic 
drugs doing the opposite.  Cholinergic drugs (which may be used for glaucoma or myasthenia gravis) 
therefore can lead to voiding of urine and anticholinergic drugs (used for COPD, urinary 
incontinence) to the retention of urine (Mtui et al, 2016). In fact, most of the medication used for 
pain relief in patients with back pain and leg pain can also cause symptoms that masquerade as CES 
(Table 2). 
 
 
 
 
 
 
 
 
Table 2 Analgesic medication used in patients with back pain and leg pain and possible CES 
symptoms 
Prescribed medication type Example Possible CES symptoms 
Opioid Salts e.g. Tramadol, codeine Constipation, reduced gastric 
motility, reduced bladder 
sensation 
Anticonvulsants e.g. Gabapentin, Pregabalin Urinary incontinence 
Antidepressants e.g. Amitriptyline, 
Nortriptyline 
Retention, sexual dysfunction, 
reduced awareness of need to 
pass urine 
NSAIDS e.g. Naproxen, Ibuprofen Retention twice as likely in 
men than women 
 
Even decongestants, over the counter cold remedies and recreational drugs can affect bladder 
function.   In relation to comorbidities, benign prostate hyperplasia is the most common cause of 
retention in men.  
Given the large number of potential causes of symptoms masquerading as CES, the clinician must be 
vigilant, thorough and considered in their approach, and must always, as directed by current 
guidelines, act immediately if CES is suspected as the cause of the symptoms (Germon et al 2015).  
Whilst this ‘safety first’ approach is likely to contribute to the high number of negative MRI scans in 
people presenting with CES-like symptoms, (a 10% finding of CES on MRI in those with signs and 
symptoms is not unusual) the clinician is bound by their duty of care to the patient to exclude CES as 
a first priority.  
CES and litigation 
According to the NHS litigation authority 293 claims were made by CES sufferers between 2010-
2015, at a cost of 25 million pounds.  In 70% of these cases, patients were aged between 31-50 years 
(NHSLA 2016). 
Consequently, the impact on Physiotherapy in the UK has in recent years become problematic due 
to increasing numbers of cases of litigation involving Physiotherapists.  For those involved in 
litigation, be that the patient or the clinician, it can be a very stressful and arduous process. It is 
essential that the clinician protects themselves and their patient by maintaining full and accurate 
records. 
As well as thorough and accurate clinical documentation, it is vital that there are clear pathways and 
protocols in place to help manage patients with suspected CES. A robust pathway that has been 
agreed by all members of the multidisciplinary team, that has been widely circulated and made 
available to all, will help everyone involved in a service manage these patients. Whilst templates are 
available for this, they need to be locally agreed to fit in with how services are configured in 
different regions and in different countries. 
A useful clinical update and accompanying video commissioned by the Chartered Society of 
Physiotherapy in the UK have recently been published which gives good advice on how to manage 
patients with suspected CES. These are available at http://www.csp.org.uk/frontline/article/clinical-
update-cauda-equina-syndrome and the video is available at; 
 https://www.youtube.com/watch?v=8rRq5QqoK3o 
  
Summary 
CES is rare but can have life changing consequences if not acted upon immediately when suspected. 
Physiotherapists can play an important role in bringing the patient and surgical team together in a 
timely manner. If surgical intervention is delayed, irreversible damage can occur to the bladder, 
bowel and sexual function with ongoing chronic pain.  Relevant symptoms which can be a precursor 
to CES are unilateral or bilateral radicular pain and/or dermatomal reduced sensation and/or 
myotomal weakness; if symptoms progress with any suggestion of changes in bladder or bowel 
function however minor, CES should be suspected (Germon et al, 2015). Emergency MRI must be 
carried out on the same day to confirm or negate CES.  The British Association of Spinal Surgeons 
(BASS) state that, ‘Nothing is to be gained by delaying surgery and potentially much to be lost’; 
surgery should be carried out as soon as is practically possible.’ (Germon et al, 2015, Todd and 
Dickson, 2016).  
Clearly not all patients with back pain will develop CES, consequently it is not necessary to warn all 
patients.  Patients who you suspect may have the potential to progress into CES, should be ‘safety 
netted’ with watchful waiting, rather than immediately referred (Underwood and Buchbinder 2013, 
Cook 2017).  Warning patients at risk is key to early diagnosis; providing these at-risk patients with 
appropriate information of what to do should CES symptoms develop can expedite a timely surgical 
opinion.   
Many patients interviewed in the Greenhalgh et al (2015) study ignored significant symptoms such 
as saddle numbness, placing more weight on their pain levels.  Some thought that saddle numbness 
was the beginning of the recovery process. Patients need to understand the relevance of their 
symptoms and of the questions being asked as they may not fully appreciate the importance and 
subsequent consequences if not explained properly.  
It is also important that a patient’s signs and symptoms are fully documented including the timing of 
examination findings so that there is a clear record of the patient’s journey. There are no predictive 
signs or symptoms of who will progress through to what stage of CES, hence the value of accurate 
and timed/dated documentation.  This paper outlines the complexity of managing patients with CES. 
Whilst the evidence continues to evolve, and will continue to produce more robust Red Flags in the 
future, the current expected best practice standards of care for this patient group is outlined. 
It is hoped that in the near future, a new clinical framework for the management of CES and other 
spinal red flags, including metastatic disease, infection and fractures, will be produced by an 
international working group supported by International Federation of Orthopaedic and Manipulative 
Physical Therapists (IFOMPT) and the Chartered Society of Physiotherapists (CSP).   
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